MarketInOut Stock Screener Log In | Sign Up

Eli Lilly & Co BDR

SAO • Healthcare • Drug Manufacturers - General • Quote as of 10/30/2026
Eli Lilly & Co BDR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeSAO
Market Capitalization6,092,604 mln
Float26,700 mln
Earnings Date10/29/2026

EPS

5.32
Stretched

P / E

48.31
High premium

Piotroski F-Score

9 / 9
Exceptional

Beneish M-Score

-2.04
Caution advised

Relative Strength

99 / 100
Top performer

Debt / Equity

1.62
High leverage

Business Description

Eli Lilly and Company is a global pharmaceutical firm founded in 1876 and based in Indianapolis, Indiana, that researches, produces, and sells medicines across the United States and many international markets. Its portfolio spans treatments for diabetes and obesity, various cancers, immune system conditions, migraines, and Alzheimer's disease. The company works alongside several partners, including Boehringer Ingelheim, Roche, and Genentech, to develop and bring new therapies to patients worldwide.

Key Fundamentals

EPS5.32
P/E48.31
ROE99.90
ROIC30.81
ROA22.74
Interest Cover131
EBITDA, mln189,979
EV / EBITDA30.66
EV / EBIT32.56
Revenue, mln420,145
EV / Revenue13.86

Quote Details

Last 257.00
Change 9.77 (3.95%)
Open 255.32
Volume 32,144
Turnover 8,261,008
Average Volume 57,969

Financial Ratios

Pre-Tax Profit Margin42
Current Ratio1.36
Price / Book31.88
Price / Tangible Book161
Price / Free Cash Flow56.63
Debt / Equity1.62
Price / Sales13.07
PEG Ratio1.42

Financial Strength

Altman Z-Score7.97
Piotroski F-Score 9 / 9
Beneish M-Score-2.04
Price to Intrinsic Value8.59
Price to Lynch Fair Value1.39
Price to Graham Number15.77
Shiller PE Ratio125

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 21.78% 99 / 100   
1 Month 28.4% 99 / 100   
2 Months 27.41% 97 / 100   
6 Months 61.14% 99 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog